The Latest Breaking News from HIV

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

West Virginia's opioid crisis is transcending partisan politics as city council candidates from three different parties tackle the issue in the capital of Charleston

In his long but fascinating memoir, the self-confessed ‘speechifying’ U2 frontman isn’t shy of exploring the roots of his pomposity, faith and ‘white saviour’ activism

Jermaine Scott, 39, was extradited from Jamaica last night and appeared in court in Warrington this morning

The city council has signed up to meet a new target which will see 95% of people with HIV given sustained antiretroviral therapy by 2025 and to end new transmissions by 2030.

This pandemic can help us prepare for the next one, says Catherine Hankins, co-chair of Canada’s COVID-19 Immunity Task Force

Gareth Thomas visited GSK House in his latest stop on the Myth Bus Tour.

Gilead Sciences reported 79% growth for its cancer drugs, helping beat expectations. On Friday, GILD stock broke out.

The maverick fly-half has been ditched by Gregor Townsend for Scotland’s autumn internationals

Mr Sunak previously said he would work "day and night to make Britain the kindest, safest and most vibrant place in the world to be LGBT”

THOUSANDS of Scots who were infected with hepatitis C or HIV by the NHS will receive £100,000 by the end of the month, the UK Government has…